Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026
Alamar Biosciences (Nasdaq: ALMR) announced it will report its second quarter 2026 financial results after market close on Monday, August 10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alamar Biosciences (Nasdaq: ALMR) announced it will report its second quarter 2026 financial results after market close on Monday, August 10, 2026. Management will host a webcast conference call at 1:30 p.m. PT / 4:30 p.m. ET, accessible via the Investors section of the company website, with an archived replay available.
Details
Market move: ALMR -3.40% in the Jul 15 session. 2Q26 earnings report date
On Jul 15, the first trading day after this news, ALMR closed 3.40% below the previous close.
Data tracked by StockTitan Argus for the Jul 15 session.
Key Figures
- Earnings release date
- August 10, 2026
- Second quarter 2026 financial results to be reported after market close
- Conference call time (PT)
- 1:30 p.m.
- Start time of Q2 2026 results webcast in Pacific Time
- Conference call time (ET)
- 4:30 p.m.
- Start time of Q2 2026 results webcast in Eastern Time
Historical Context
-
National proteomics initiative profiling 21,000 plasma samples from 10,000 participants.
-
NULISA platform featured in over 140 AAIC 2026 presentations.
-
Launch of first multiplexed blood-based immunoassay for eMTBR-Tau.
-
Q1 2026 revenue rose to $26.0M with 99% year-over-year growth.
-
Planned presentation at BofA Securities 2026 Healthcare Conference.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FREMONT, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will report financial results for the second quarter 2026 after market close on Monday, August 10, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the “Investors” section of the company website at: www.alamarbio.com. The webcast will be archived and available for replay after the event.
About Alamar Biosciences
Alamar is a commercial-stage proteomics company establishing a gold standard in protein detection and analysis. Leveraging our proprietary NULISA™ technology and the ARGO™ HT System, our platform is designed to detect protein biomarkers at extremely low concentrations in blood with ultra-high sensitivity, high specificity, flexible multiplexing, broad dynamic range and seamless automation. We refer to this combination of features as “Precision Proteomics,” and believe it fills a critical gap in the field of advanced proteomics, helping researchers unlock the full spectrum of protein biomarkers across disease states. Learn more at alamarbio.com.
Investor contact:
Media contact:
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.